Reasons for buying:
Market Cap: ₹17,735.88 Cr
Debt to Equity: 0
Return on Equity 5Y Avg: 23.83%
EPS - 5Y Growth: 25.43%
Price-earnings to growth (5Y): 1.07
5Y RoE Consistency - Sustained without losing 20% in any year
Buy date: 04-Mar-2022
Qty: 1 Buy Price: ₹7400 Buy EPS: 410.06 Buy PE: 18.04
Will continue to add when a stock falls 10% as long as the ratios remain the same.
Sanofi India is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous system, and anti-histamines. the company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a company of its growth strategy.
No comments:
Post a Comment